Embarc

Leadership

Kishen Mehta

SPACs
4
$200M
Biotech
DNAA
  1. Registration
  2. IPO
  3. Definitive Agreement
  4. Completed
Completed
Social Capital Suvretta Holdings Corp. I
Akili Interactive
AKLI97%
$200M
Biotech
DNAB
  1. Registration
  2. IPO
  3. Definitive Agreement
  4. Failed
Failed
Social Capital Suvretta Holdings Corp. II
$200M
Biotech
DNAC
  1. Registration
  2. IPO
  3. Definitive Agreement
  4. Completed
Completed
Social Capital Suvretta Holdings Corp. III
ProKidney
PROK85%
$200M
Biotech
DNAD
  1. Registration
  2. IPO
  3. Definitive Agreement
  4. Failed
Failed
Social Capital Suvretta Holdings Corp. IV